Table 1.
Core targets of Rosa roxburghii Tratt fruit in the treatment of T2DM
Number | Core targets | Degree | Betweenness | Closeness |
---|---|---|---|---|
1 | AKT1 | 128 | 4132.90 | 0.71 |
2 | TNF | 124 | 3789.15 | 0.69 |
3 | SRC | 108 | 1936.38 | 0.66 |
4 | VEGFA | 105 | 1366.52 | 0.65 |
5 | EGFR | 98 | 1590.71 | 0.64 |
6 | CASP3 | 97 | 1146.73 | 0.64 |
7 | MAPK3 | 96 | 1249.94 | 0.63 |
8 | STAT3 | 94 | 1136.86 | 0.63 |
9 | PPARG | 85 | 2597.99 | 0.61 |
10 | ESR1 | 83 | 1270.22 | 0.60 |
11 | mTOR | 81 | 980.66 | 0.61 |
12 | PTGS2 | 79 | 1135.57 | 0.60 |
13 | MAPK1 | 78 | 1111.02 | 0.60 |
AKT1 serine/threonine kinase 1, TNF tumor necrosis factor, SRC steroid receptor coactivator, VEGFA vascular endothelial growth factor A, EGFR epidermal growth factor receptor, CASP3 caspase-3, MAPK3 mitogen-activated protein 3, STAT3 signal transducer and activator of transcription 3, PPARG peroxisome proliferator-activated receptor gamma, ESR1 estrogen receptor 1, mTOR mammalian target of rapamycin, PTGS2 prostaglandin-endoperoxide synthase 2, MAPK1 mitogen-activated protein kinase 1